Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III … – Trading Markets (press release)
posted on Dec 22 by pregnancy hypertension - Google News in the Uncategorized categoryNovartis to acquire Corthera Inc., gaining worldwide rights to Phase III ... Trading Markets (press release) [2] * Tekturna/Rasilez(aliskiren) ? a first-in-class direct renin inhibitor approved for treatment of hypertension that is also currently in Phase III ... |



